# FDA Inspection 1101901 - Biomat USA, Inc. - August 20, 2019

Source: https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/ff01a836-04af-43de-8eae-ca3a2317828b/
Source feed: FDA_Inspections

> FDA Inspection 1101901 for Biomat USA, Inc. on August 20, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1101901
- Company Name: Biomat USA, Inc.
- Inspection Date: 2019-08-20
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 831921 - 2013-05-09](https://www.globalkeysolutions.net/api/records/fda_inspections/biomat-usa-inc/ccf6a384-8469-4777-a97c-d68f73cb528c/)
- [FDA Inspection 732423 - 2011-06-28](https://www.globalkeysolutions.net/api/records/fda_inspections/biomat-usa-inc/72d37285-842c-4583-a8d8-40c3bb17904d/)

Company: https://www.globalkeysolutions.net/companies/biomat-usa-inc/6c7234ca-069a-43ac-bc37-3dc3211a9cbb

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d